NIH-funded research R01 grant

Peripheral immune signals and blood vessel health in aging and dementia

Official title: Peripheral immunity and the aging brain: Studying the relationship of platelet and neutrophil activity with markers of vascular contributions to cognitive decline and dementia

Funded at New York University School of Medicine · NIH-11413466 · Data updated 2026-11-12

This project looks at how platelet and neutrophil activity relate to brain changes and biomarkers of Alzheimer’s disease in older adults, especially those at higher cardiovascular risk.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 15, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$1,547,425
NIH project number5R01AG092953-02
Project IDNIH-11413466 on NIH RePORTER

Who could benefit from this research

Could help

Older adults at risk for dementia or with elevated cardiovascular risk, including diverse populations from cohorts like Framingham and ARISE-DP.

Less likely to help

People without risk factors or dementia pathology may not see a direct benefit.

What this research studies

If funded, researchers will study blood markers of vascular and immune function alongside brain imaging to understand how blood vessel health and inflammation influence Alzheimer’s disease progression. They will use data from the Framingham Heart Study and the ARISE-DP cohort to examine how platelet activity, neutrophil levels, and proteomic data relate to MRI and PET biomarkers of vascular burden, amyloid, and tau. The goal is to clarify how vascular problems and immune signals combine to affect dementia risk in diverse populations. This work could help identify which patients might benefit most from interventions targeting vascular health and inflammation. The study emphasizes collaboration across specialties and advanced imaging and biofluid analyses to map these complex relationships.

Why it matters

Potential benefit: Better understanding of who is at risk and how vascular and immune factors contribute to dementia could guide prevention and treatment strategies.

How similar studies have gone: Previous work shows associations between vascular/inflammatory markers and AD biomarkers, supporting potential validity of this approach.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Ramos-Cejudo, Jaime — New York University School of Medicine
  • Study coordinator: Ramos-Cejudo, Jaime

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.